Published in J Clin Microbiol on December 01, 1977
Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol (2002) 2.14
Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris. J Invest Dermatol (2008) 1.55
Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun (1995) 1.37
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol (2009) 1.35
Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiol (2010) 1.28
Biochemical, enzymatic, and serological differentiation of Peptococcus indolicus (Christiansen) Sørensen from Peptococcus asaccharolyticus (Distaso) Douglas. J Clin Microbiol (1979) 1.23
Protease-activated receptor-2 mediates the expression of inflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases in keratinocytes in response to Propionibacterium acnes. Arch Dermatol Res (2010) 0.97
Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria. PLoS One (2014) 0.87
Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne. J Clin Aesthet Dermatol (2011) 0.80
Propionibacterium acnes activates the NLRP3 inflammasome in human sebocytes. J Invest Dermatol (2014) 0.79
A small peptide with therapeutic potential for inflammatory acne vulgaris. PLoS One (2013) 0.77
Hyaluronidase in Clinical Isolates of Propionibacterium acnes. Int J Bacteriol (2015) 0.76
p38 MAP Kinase Inhibition Reduces Propionibacterium acnes-Induced Inflammation in Vitro. Dermatol Ther (Heidelb) (2015) 0.75
Assessment of a new biological complex efficacy on dysseborrhea, inflammation, and Propionibacterium acnes proliferation. Clin Cosmet Investig Dermatol (2016) 0.75
Inhibition of lipase and inflammatory mediators by Chlorella lipid extracts for antiacne treatment. J Adv Pharm Technol Res (2015) 0.75
Identification of Staphylococcus pyogenes by the phosphatase reaction. J Pathol Bacteriol (1951) 10.40
Cell wall composition and deoxyribonucleic acid similarities among the anaerobic coryneforms, classical propionibacteria, and strains of Arachnia propionica. J Bacteriol (1972) 3.43
Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl Microbiol (1968) 2.94
Corynebacterium acnes and other anaerobic diphtheroids from human skin. J Med Microbiol (1974) 2.18
Phosphatase activity of anaerobic organisms. Appl Microbiol (1974) 2.09
Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother (1976) 1.44
Differentiation of two groups of Corynebacterium acnes. J Bacteriol (1970) 1.36
Studies on bacteriophages of Propionibacterium acnes. Med Microbiol Immunol (1975) 1.33
Extracellular deoxyribonuclease production by anaerobic bacteria. Appl Microbiol (1974) 1.28
The production of hyaluronidase (hyaluronate lyase) by Corynebacterium acnes. J Invest Dermatol (1972) 1.07
[Lipase and lecithinase activities of aerobic and anaerobic Corynebacterium and Propionibacterium species]. Zentralbl Bakteriol Orig (1967) 1.01
[Bacteriophages of Propionibacterium acnes (author's transl)]. Zentralbl Bakteriol Orig A (1973) 1.01
Acne vulgaris and free fatty acids. A review and criticism. Arch Dermatol (1974) 0.99
[Natural occurrence and clinical importance of gram-positive, non-spore-forming anaerobes]. Zentralbl Bakteriol Orig A (1974) 0.91
Problems of human actinomycosis. Postepy Hig Med Dosw (1974) 0.90
Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. Antimicrob Agents Chemother (1976) 1.44
Nasal carriage of Staphylococcus aureus and its influence on hospital infections caused by methicillin-resistant strains. Zentralbl Bakteriol (1990) 0.83
The feasibility of replacing antibiotics by quaternary ammonium compounds in topical antimicrobial acne therapy. Arch Dermatol Res (1979) 0.76
[Characteristics of Propionibacterium strains isolated from patients with acne juvenilis and from healthy persons]. Med Dosw Mikrobiol (1984) 0.75